CN106136247A - A kind of Semen Phaseoli Vulgaris many certain kind of berries compositions and preparation method thereof - Google Patents
A kind of Semen Phaseoli Vulgaris many certain kind of berries compositions and preparation method thereof Download PDFInfo
- Publication number
- CN106136247A CN106136247A CN201610515953.0A CN201610515953A CN106136247A CN 106136247 A CN106136247 A CN 106136247A CN 201610515953 A CN201610515953 A CN 201610515953A CN 106136247 A CN106136247 A CN 106136247A
- Authority
- CN
- China
- Prior art keywords
- berries
- semen phaseoli
- fruit powder
- certain kind
- compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 53
- 210000000582 semen Anatomy 0.000 title claims abstract description 49
- 235000021028 berry Nutrition 0.000 title claims abstract description 44
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 72
- 239000000843 powder Substances 0.000 claims abstract description 71
- 235000013325 dietary fiber Nutrition 0.000 claims abstract description 14
- 150000005846 sugar alcohols Chemical class 0.000 claims abstract description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 13
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 claims description 18
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 claims description 14
- 239000004375 Dextrin Substances 0.000 claims description 13
- 229920001353 Dextrin Polymers 0.000 claims description 13
- 235000019425 dextrin Nutrition 0.000 claims description 13
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 12
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 12
- 239000000811 xylitol Substances 0.000 claims description 12
- 235000010447 xylitol Nutrition 0.000 claims description 12
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 12
- 229960002675 xylitol Drugs 0.000 claims description 12
- 239000007787 solid Substances 0.000 claims description 10
- 229940013618 stevioside Drugs 0.000 claims description 10
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims description 10
- 235000019202 steviosides Nutrition 0.000 claims description 10
- 229920001100 Polydextrose Polymers 0.000 claims description 9
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims description 9
- 240000000851 Vaccinium corymbosum Species 0.000 claims description 9
- 235000003095 Vaccinium corymbosum Nutrition 0.000 claims description 9
- 235000017537 Vaccinium myrtillus Nutrition 0.000 claims description 9
- 235000021014 blueberries Nutrition 0.000 claims description 9
- 239000001259 polydextrose Substances 0.000 claims description 9
- 235000013856 polydextrose Nutrition 0.000 claims description 9
- 229940035035 polydextrose Drugs 0.000 claims description 9
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 claims description 8
- 235000013361 beverage Nutrition 0.000 claims description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- 240000001717 Vaccinium macrocarpon Species 0.000 claims description 5
- 235000012545 Vaccinium macrocarpon Nutrition 0.000 claims description 5
- 235000002118 Vaccinium oxycoccus Nutrition 0.000 claims description 5
- 235000004634 cranberry Nutrition 0.000 claims description 5
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 4
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 4
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 4
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 4
- 239000004386 Erythritol Substances 0.000 claims description 4
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims description 4
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 4
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 4
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims description 4
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims description 4
- 235000019414 erythritol Nutrition 0.000 claims description 4
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims description 4
- 229940009714 erythritol Drugs 0.000 claims description 4
- 239000008101 lactose Substances 0.000 claims description 4
- 239000000600 sorbitol Substances 0.000 claims description 4
- 235000010356 sorbitol Nutrition 0.000 claims description 4
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 claims description 3
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 3
- 244000207620 Euterpe oleracea Species 0.000 claims description 3
- 235000012601 Euterpe oleracea Nutrition 0.000 claims description 3
- 229930195725 Mannitol Natural products 0.000 claims description 3
- 235000003650 acai Nutrition 0.000 claims description 3
- 235000010358 acesulfame potassium Nutrition 0.000 claims description 3
- 229960004998 acesulfame potassium Drugs 0.000 claims description 3
- 239000000619 acesulfame-K Substances 0.000 claims description 3
- 239000000835 fiber Substances 0.000 claims description 3
- 229930182470 glycoside Natural products 0.000 claims description 3
- 239000000594 mannitol Substances 0.000 claims description 3
- 235000010355 mannitol Nutrition 0.000 claims description 3
- 108010011485 Aspartame Proteins 0.000 claims description 2
- 239000004376 Sucralose Substances 0.000 claims description 2
- 239000000605 aspartame Substances 0.000 claims description 2
- 235000010357 aspartame Nutrition 0.000 claims description 2
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims description 2
- 229960003438 aspartame Drugs 0.000 claims description 2
- 229930182830 galactose Natural products 0.000 claims description 2
- 150000002338 glycosides Chemical class 0.000 claims description 2
- 235000019408 sucralose Nutrition 0.000 claims description 2
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 claims description 2
- 235000009508 confectionery Nutrition 0.000 claims 1
- 239000002023 wood Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 30
- 230000036541 health Effects 0.000 abstract description 7
- 230000037356 lipid metabolism Effects 0.000 abstract description 5
- 235000015097 nutrients Nutrition 0.000 abstract description 5
- 238000007493 shaping process Methods 0.000 abstract description 5
- 239000002994 raw material Substances 0.000 abstract description 3
- 230000000052 comparative effect Effects 0.000 description 37
- 230000001603 reducing effect Effects 0.000 description 15
- 238000012360 testing method Methods 0.000 description 15
- 239000000047 product Substances 0.000 description 14
- 238000000034 method Methods 0.000 description 13
- 208000020442 loss of weight Diseases 0.000 description 12
- 208000008589 Obesity Diseases 0.000 description 9
- 238000010521 absorption reaction Methods 0.000 description 9
- 235000020824 obesity Nutrition 0.000 description 9
- 239000000463 material Substances 0.000 description 7
- 230000008569 process Effects 0.000 description 6
- 208000016261 weight loss Diseases 0.000 description 6
- 230000004580 weight loss Effects 0.000 description 6
- 206010033307 Overweight Diseases 0.000 description 5
- 235000016709 nutrition Nutrition 0.000 description 5
- 210000000577 adipose tissue Anatomy 0.000 description 4
- 230000037396 body weight Effects 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 235000013402 health food Nutrition 0.000 description 3
- 238000007689 inspection Methods 0.000 description 3
- 229960001375 lactose Drugs 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 230000036186 satiety Effects 0.000 description 3
- 235000019627 satiety Nutrition 0.000 description 3
- 229960002920 sorbitol Drugs 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- LWTDZKXXJRRKDG-KXBFYZLASA-N (-)-phaseollin Chemical compound C1OC2=CC(O)=CC=C2[C@H]2[C@@H]1C1=CC=C3OC(C)(C)C=CC3=C1O2 LWTDZKXXJRRKDG-KXBFYZLASA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 240000007930 Oxalis acetosella Species 0.000 description 2
- 235000008098 Oxalis acetosella Nutrition 0.000 description 2
- 235000010240 Paullinia pinnata Nutrition 0.000 description 2
- 244000045930 Phaseolus coccineus Species 0.000 description 2
- 244000046052 Phaseolus vulgaris Species 0.000 description 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 235000019577 caloric intake Nutrition 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 238000002651 drug therapy Methods 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 235000012631 food intake Nutrition 0.000 description 2
- 230000037406 food intake Effects 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 208000003532 hypothyroidism Diseases 0.000 description 2
- 230000002989 hypothyroidism Effects 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 229960001855 mannitol Drugs 0.000 description 2
- 239000011812 mixed powder Substances 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000000291 postprandial effect Effects 0.000 description 2
- 230000004224 protection Effects 0.000 description 2
- 230000005180 public health Effects 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 210000000697 sensory organ Anatomy 0.000 description 2
- 238000013112 stability test Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 101710171801 Alpha-amylase inhibitor Proteins 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000014311 Cushing syndrome Diseases 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 208000032928 Dyslipidaemia Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 208000037171 Hypercorticoidism Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010062767 Hypophysitis Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- LKDRXBCSQODPBY-AMVSKUEXSA-N L-(-)-Sorbose Chemical compound OCC1(O)OC[C@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-AMVSKUEXSA-N 0.000 description 1
- 208000017170 Lipid metabolism disease Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- VCUFZILGIRCDQQ-KRWDZBQOSA-N N-[[(5S)-2-oxo-3-(2-oxo-3H-1,3-benzoxazol-6-yl)-1,3-oxazolidin-5-yl]methyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C1O[C@H](CN1C1=CC2=C(NC(O2)=O)C=C1)CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F VCUFZILGIRCDQQ-KRWDZBQOSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 101710163504 Phaseolin Proteins 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000037063 Thinness Diseases 0.000 description 1
- 244000185386 Thladiantha grosvenorii Species 0.000 description 1
- 235000011171 Thladiantha grosvenorii Nutrition 0.000 description 1
- 235000009392 Vitis Nutrition 0.000 description 1
- 241000219095 Vitis Species 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 201000005255 adrenal gland hyperfunction Diseases 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000003392 amylase inhibitor Substances 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 238000012550 audit Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 230000005961 cardioprotection Effects 0.000 description 1
- 229960004203 carnitine Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000002485 combustion reaction Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 235000020940 control diet Nutrition 0.000 description 1
- 230000002478 diastatic effect Effects 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 230000004129 fatty acid metabolism Effects 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 235000021474 generally recognized As safe (food) Nutrition 0.000 description 1
- 235000021473 generally recognized as safe (food ingredients) Nutrition 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 210000002149 gonad Anatomy 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 210000003016 hypothalamus Anatomy 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 150000004668 long chain fatty acids Chemical class 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 210000001700 mitochondrial membrane Anatomy 0.000 description 1
- 229930189775 mogroside Natural products 0.000 description 1
- 210000001087 myotubule Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 238000003305 oral gavage Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- LWTDZKXXJRRKDG-UHFFFAOYSA-N phaseollin Natural products C1OC2=CC(O)=CC=C2C2C1C1=CC=C3OC(C)(C)C=CC3=C1O2 LWTDZKXXJRRKDG-UHFFFAOYSA-N 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 235000021251 pulses Nutrition 0.000 description 1
- UNAANXDKBXWMLN-UHFFFAOYSA-N sibutramine Chemical compound C=1C=C(Cl)C=CC=1C1(C(N(C)C)CC(C)C)CCC1 UNAANXDKBXWMLN-UHFFFAOYSA-N 0.000 description 1
- 229960004425 sibutramine Drugs 0.000 description 1
- -1 stevioside Glycosides Chemical class 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 235000021092 sugar substitutes Nutrition 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 206010048828 underweight Diseases 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a kind of Semen Phaseoli Vulgaris many certain kind of berries compositions and preparation method thereof.Said composition includes Semen Phaseoli Vulgaris extract 2 20 parts, L-carnitine-L-tartrate 0.1 6 parts, water soluble dietary fiber 30 70 parts, many certain kind of berries fruit powder 5 30 parts, sugar alcohol 5 40 parts, correctives 0 0.5 parts.Compositions of the present invention contains various nutrient elements, by selecting suitable raw material and proportioning thereof, reaches fat-reducing body shaping, promotes lipid metabolism and effect of safety and Health.
Description
Technical field
The invention belongs to field of food, relate to a kind of body shaping of can losing weight, promote lipid metabolism and the white rue of safety and Health
Bean many certain kind of berries compositions.
Background technology
At present, obesity has become as a common fault in the whole world.Whether developed country or developing country, fat number
To a breakneck stage.2014 World Health Organization (WHO) " fat and overweight " commentary (No. 311) show
Having shown: since 1980, world's obesity number increases by about one time；2008,20 years old and above adult have more than 14
Hundred million people are overweight (accounting for total population 35%).Wherein male more than 200,000,000 and nearly 300,000,000 women are fat；The world population of 65% is lived
Country, dies from overweight and fat number more than dying from underweight number.2011, more than 4000, less than 10,000 years old child surpassed
Weight.Within 2013,20-69 year crowd's physical fitness activity and the physical condition of 4.3 ten thousand examples are taken a sample test investigation by Chinese sports general bureau
Display: the overweight and obese people of China has reached 47.1%.The fat danger brought to human survival is day by day by people
Being paid attention to, obesity has been defined as a kind of disease rather than simple overweight by WHO.And obesity with " prevalence is high,
Complication is many, hazardness weight " etc. feature be identified as unhealthful the fifth-largest risk factor.Experimentation proves, by obesity
The triglyceride accumulation produced, carbohydrate and lipid metabolism are abnormal, not only affect pretty figure, more cause internal some interior point
Krinin changes, thus causes the generation of the diseases such as cardiovascular disease, diabetes, hypertension, dyslipidemia.Obesity also can be made
For some disease, such as hypothalamus, hypophysis inflammation, tumor, wound, hypercortisolism, hypothyroidism (hypothyroidism), gonad
One of clinical manifestation of hypofunction.
At present, treatment 2 key links of obesity are to reduce calorie intake and increase heat consumption.Mode has control drink
Food, increase physical exertion, Drug therapy and surgical operation therapy etc..Wherein, conscious long-term control diet and increase physical exertion
It is most important means, it should be clear that be not equal to loss of weight by body-shaping slimming, because fat mainly fat exceeds standard,
And shaping is much quickly to deduct internal water, do not reduce fat ratio；Drug therapy and surgical operation are mainly used in
Severe simple obesity, all has the spirit aspect untoward reaction such as gastrointestinal side effect in various degree or anxiety, excitement, insomnia.
Also have health food or the bread and cheese being much turned on fat-reducing banner on market, but some is illegally to add chemistry
Medicine, such as sibutramine；Some is only the absorption of simple inhibiting substances energy, controls nutrition intake, and can not subtract by selectivity
Few sugar, the absorption of lipid, so, it is provided that a kind of safety and Health, the obvious health food of fat reducing slimming effect are that market institute is anxious
Need.
Summary of the invention
It is an object of the present invention to provide a kind of Semen Phaseoli Vulgaris many certain kind of berries compositions, said composition contains various nutrient elements,
By selecting suitable raw material and proportioning thereof, reach fat-reducing body shaping, promote lipid metabolism and effect of safety and Health.
It is a further object to provide the preparation method of a kind of Semen Phaseoli Vulgaris many certain kind of berries compositions.
For reaching above-mentioned purpose, the present invention uses following technical proposals:
The present invention provides a kind of Semen Phaseoli Vulgaris many certain kind of berries compositions, and it includes: Semen Phaseoli Vulgaris extract 2-20 part, L-carnitine winestone
Hydrochlorate 0.1-6 part, water soluble dietary fiber 30-70 part, many certain kind of berries fruit powder 5-30 part, sugar alcohol 5-40 part, correctives 0-0.5 part.
In the present compositions, described many certain kind of berries fruit powder refers to the fruit powder being made up of multiple certain kind of berries fruit.Preferably, described many
Certain kind of berries fruit powder is at least two in Fructus Fragariae Ananssae fruit powder, Fructus Rubi fruit powder, blueberry powder, Brazilian Acai fruit powder and cranberry fruit powder.
Further, described water soluble dietary fiber is resistant dextrin, oligofructose, oligomeric galactose, oligomeric xylose, gathers
One or more in glucose and Rhizoma amorphophalli fiber.
Described sugar alcohol is the one in maltose alcohol, xylitol, Sorbitol, mannitol, erythritol and lactose
Or it is several.
Can also add correctives in the present compositions, described correctives is kind commonly used in the art.Preferably
Ground, described correctives is mogroside, one or more in stevioside, sucralose, aspartame and acesulfame potassium.
As the improvement project of above-mentioned composition, said composition can also be added various fruit fruit powder, including but do not limit
In, one or more in apple power, Fructus Musae fruit powder and Fructus actinidiae chinensis fruit powder.The consumption of described fruit fruit powder is 1-10 part.
In the compositions of the invention described above, Semen Phaseoli Vulgaris extract: derive from pulse family and belong to scarlet runner bean phaseolus
The fruit of coccineus L., P.multiflorus willd, originates in Mexico and Argentina.Semen Phaseoli Vulgaris rich in nutritive value,
Every dry bean of 100g contains protein 19.9%-20.0%.There is warming the middle warmer and descending qi, profit the intestines and stomach, the effect of kidney tonifying invigorating primordial QI.It contains
Semen Phaseoli Vulgaris albumen (also known as phaseolin) be a kind of natural alpha-amylase inhibitor, can effectively block diastatic activity, and not
Act on human organ, calorie intake and adipose-derived and do not affect the absorption of other nutrient substance can be reduced, there is no discovery and appoint
What toxic and side effects, clinical application proves that have effect of weight reducing, post-prandial glycemia can be suppressed to rise simultaneously.Semen Phaseoli Vulgaris used in the present invention
Extract can be prepared voluntarily by art methods, it is also possible to commercially available.Through the great many of experiments of inventor, at this
In bright preferred embodiment, present invention preferably employs the Semen Phaseoli Vulgaris extract being derived from U.S. pharmachem, be the U.S. only
One by FDA fat-reducing certification and the native starch blocker of GRAS safety certification, and the Health Claims license of U.S. FDA.Also
It it is the first Starch blockers by 29 clinical verifications in the whole world.Administrative permission technological audit meaning according to Ministry of Public Health in 2011
Seeing, Semen Phaseoli Vulgaris extract can use as bread and cheese.
L-carnitine-L-tartrate: L-carnitine, also known as L-BETAIN, is the lipometabolic necessary factor, as carrier
Promote the oxidation of fatty acid in long-chain fatty acid can be transported to from mitochondrial membrane film, be that one can promote adipose conversion to be energy
The amino acid of amount, while reducing fat, does not reduce internal water and muscle, to human non-toxic's side effect, routing motion
Lipid metabolism can be more efficiently facilitated.Within 1985, in the international nutrition academic conference that Chicago is held, L-carnitine is appointed as
" multifunctional and nutritional product ".Anti-tissue is considered the fat-reducing nutrient complementary goods of safe without toxic side effect by it by International Obesity.As
The most internal shortage L-carnitine, will result in fatty acid metabolism disorderly, causes two kinds of consequences: (1) cause muscle supplying energy not
Foot, produces the heart disease that human body is tired and relevant；(2) cause lipid material to accumulate in muscle fiber and liver, produce fertilizer
Fat, fatty liver diseases.The obese type people that motion is not enough, often supplements L-carnitine, is kept taking exercise, it becomes possible to consumer
The fatty acid of interior accumulation, plays the effect of fat-reducing.But L-carnitine is the most unstable, and conventional L-carnitine-L-tartrate replaces a left side
Rotation carnitine.It is difficult to the moisture absorption, keeps stable in humid conditions.
This compositions use Semen Phaseoli Vulgaris extract coordinate L-carnitine-L-tartrate can reduce the absorption of fat, pile up also
Promote fat combustion, thus reach the purpose of fat-reducing.Additionally, by adding many certain kind of berries fruit powder, provide multivitamin for body, can
Increase health desired nutritional and adjust mouthfeel.Additionally, containing multiple dietary fiber in certain kind of berries class fruit powder, such as pectin, insoluble meals
Fibers etc., can increase satiety, accelerate fat discharge in intestinal；Can with Semen Phaseoli Vulgaris extract, L-carnitine synergism,
Improve fat-reducing effect.
Water soluble dietary fiber: dietary fiber is a kind of special nutrient, its essence is can not be by carbohydrate
The polysaccharose substance that human digestive enzymes is decomposed.Wherein, water soluble dietary fiber is a kind of high-effect dietary fiber, is dissolved in water
After, it is impossible to digested, but cholesterol and blood glucose can be reduced, cardioprotection blood vessel.Additionally, water soluble dietary fiber caloric value is relatively
Low, there is the good effect promoting satiety, can appetite-suppressing, reduce food-intake, and unnecessary fat can be taken away in human body
Fat and energy.
Sugar alcohol: sugar alcohol is a kind of polyhydric alcohol, containing plural hydroxyl.The most conventional has Sorbitol, mannose
Alcohol, erythritol, maltose alcohol, lactose, xylitol etc., these sugar alcohols have higher stability to acid, heat, are widely used
In low calorie foods formula.The most using sugar alcohol as sugar substitute.
Present invention also offers the preparation method of above-mentioned Semen Phaseoli Vulgaris many certain kind of berries compositions, the method includes: take described Semen Phaseoli Vulgaris
Extract, water soluble dietary fiber, sugar alcohol sieve respectively, mixing, obtain mixture 1；Take described many certain kind of berries fruit powder, L-carnitine winestone
Hydrochlorate, correctives sieve respectively, mixing, obtain mixture 2；Mixture 1 and mixture 2 are mixed, pack and get final product.
Further, in said method, when preparing mixture 2, also include the fruit fruit powder adding 1-10 part, it is preferable that
Described fruit fruit powder is one or more in apple power, Fructus Musae fruit powder and Fructus actinidiae chinensis fruit powder.
In a preferred embodiment of the invention, the present invention protects a kind of Semen Phaseoli Vulgaris many certain kind of berries compositions further, should
Compositions includes: Semen Phaseoli Vulgaris extract 2-20 part, L-carnitine-L-tartrate 0.1-6 part, resistant dextrin 20-45 part, poly-Fructus Vitis viniferae
Sugar 10-25 part, xylitol 20-30 part, Fructus Fragariae Ananssae fruit powder 1-10 part, Fructus Rubi fruit powder 2-10 part, blueberry powder 2-10 part and stevioside
Glycosides 0-0.5 part.Additionally, the present invention also protects the solid beverage including above-mentioned Semen Phaseoli Vulgaris many certain kind of berries compositions, this solid beverage is permissible
Prepared by the conventional method of this area, such as directly by described Semen Phaseoli Vulgaris many certain kind of berries compositions quantitative package, it is also possible to add each
Plant adjuvant, granular form solid beverage, effervescence type solid beverage etc..
Beneficial effects of the present invention is as follows:
This product can control the absorption of heat with number of ways: Semen Phaseoli Vulgaris extract reduces the absorption of starch, and then reduces sugar
The absorption of class, decreases sugar from source and post-prandial glycemia can be suppressed to rise to the conversion of fat simultaneously.The dietary fiber added can
Produce satiety, reduce food-intake, and then reduce fat and the absorption of carbohydrate.L-carnitine routing motion can accelerate fat
The metabolism of fat.Adding multiple certain kind of berries class, nutrition is delicious, auxiliary fat-reducing.Primary raw material safety is high.Additionally, this product uses sugar-free to join
Side, diabetes patient also can relieved eat.
Detailed description of the invention
In order to be illustrated more clearly that the present invention, below in conjunction with preferred embodiment, the present invention is described further.Ability
Field technique personnel should be appreciated that following specifically described content is illustrative and be not restrictive, and should not limit this with this
The protection domain of invention.
Embodiment 1
Formula for a product: Semen Phaseoli Vulgaris extract 8 parts, L-carnitine-L-tartrate 0.8 part, resistant dextrin 43 parts, polydextrose
13 parts, xylitol 20 parts, Fructus Fragariae Ananssae fruit powder 5 parts, Fructus Rubi fruit powder 5 parts, blueberry powder 5 parts, stevioside 0.2 part.
Preparation method is as follows:
1, take formula ratio Semen Phaseoli Vulgaris extract, resistant dextrin, polydextrose, xylitol sieve respectively, mix standby；
2, recipe quantity Fructus Fragariae Ananssae fruit powder, Fructus Rubi fruit powder, blueberry powder, stevioside, L-carnitine-L-tartrate mistake respectively are taken
Sieve, quantitative package after mixing with the mixture in method 1 after mixing.
Embodiment 2
Formula for a product: Semen Phaseoli Vulgaris extract 20 parts, L-carnitine-L-tartrate 3.9 parts, oligomeric xylose 20 parts, oligofructose
20 parts, blueberry powder 5 parts, Fructus Rubi fruit powder 5 parts, cranberry fruit powder 5 parts, maltose alcohol 10 parts, erythritol 11 parts, momordica grosvenori sugar
Glycosides 0.1 part.
Preparation method is with embodiment 1.
Embodiment 3
Formula for a product: Semen Phaseoli Vulgaris extract 10 parts, L-carnitine-L-tartrate 3.5 parts, resistant dextrin 20 parts, oligomeric gala
Sugar 15 parts, oligomeric xylose 15 parts, Fructus Fragariae Ananssae fruit powder 5 parts, cranberry fruit powder 10 parts, Fructus Musae fruit powder 10 parts, xylitol 7 parts, sorbose
Alcohol 7 parts, mannitol 7 parts, acesulfame potassium 0.5 part.
Preparation method difference from Example 1 is to use conventional method by mixed powder granular form solid beverage.
Embodiment 4
Formula for a product: Semen Phaseoli Vulgaris extract 12 parts, L-carnitine-L-tartrate 4 parts, resistant dextrin 32 parts, oligofructose 30
Part, cranberry fruit powder 8 parts, Brazilian Acai fruit powder 3 parts, Sorbitol 6 parts, lactose 5 parts.
Preparation method difference from Example 1 is to use conventional method that mixed powder is made effervescence type solid beverage.
Embodiment 5
Formula for a product: Semen Phaseoli Vulgaris extract 8 parts, L-carnitine-L-tartrate 2.5 parts, resistant dextrin 20 parts, polydextrose
25 parts, xylitol 24 parts, Fructus Fragariae Ananssae fruit powder 6 parts, Fructus Rubi fruit powder 5.4 parts, blueberry powder 9 parts, stevioside 0.1 part.
Preparation method is with embodiment 1.
Comparative example 1
Formula for a product: Semen Phaseoli Vulgaris extract 8 parts, L-carnitine-L-tartrate 0.8 part, resistant dextrin 43 parts, polydextrose
18 parts, xylitol 30 parts, stevioside 0.2 part.
Preparation method is with embodiment 1.
Comparative example 2
Formula for a product: Semen Phaseoli Vulgaris extract 8 parts, L-carnitine-L-tartrate 15 parts, resistant dextrin 43 parts, polydextrose 13
Part, xylitol 21 parts, stevioside 0.2 part.
Preparation method is with embodiment 1.
Comparative example 3
Formula for a product: Semen Phaseoli Vulgaris extract 8 parts, resistant dextrin 43 parts, polydextrose 13 parts, xylitol 20.8 parts, Fructus Fragariae Ananssae
Fruit powder 5 parts, Fructus Rubi fruit powder 5 parts, blueberry powder 5 parts, stevioside 0.2 part.
Preparation method is with embodiment 1.
Comparative example 4
Formula for a product: Semen Phaseoli Vulgaris extract 8 parts, resistant dextrin 43 parts, polydextrose 18 parts, xylitol 30.8 parts, Flos Chrysanthemi
0.2 part of glucosides.
Test example 1 stability study
Take the solid composite that the present embodiment 2 prepares, by placing 3 under Accelerated stability test (37 DEG C, 75% humidity)
Individual month, respectively 0 month, 1 week, 2 weeks, 3 weeks, 1 month, 2 months, 3 months time take sample and carry out sensory evaluation, result of the test sees below
Table 1.
Table 1 stability test result
Result shows, the solid composite that the present embodiment prepares, and under the conditions of the accelerated test of 37 DEG C and 75% humidity, has
There is obvious stability.Similarly, the compositions that prepared by other embodiments also has obvious stability.
Test example 2 Piglet s colibacillosis
Test method testing program is with reference to former Ministry of Public Health " health food inspection and value disciplines " (version in 2003) " function assessment
Assessment process and the method for inspection, the weight losing function animal experiment method of inspection " it is designed.After modeling success, rat random packet.
Obese model group rat gives conventional foundation feedstuff, embodiment 1 group, comparative example 1 group, comparative example 2 groups, comparative example 3 groups, comparative example
4 groups (concrete proportioning is shown in Table 2) set Isodose gastric infusion, give 6 weeks continuously.
Before and after administration, rat is weighed；Cut open the belly during off-test and take body fat (testis and perinephric fat pad) and weigh, and
Calculate fat coefficient (body fat weight/end body weight).
Table 2 tested material composition and ratio
Result of the test:
1, different tested materials process the impact on test Mus body weight and are shown in Table 3.
The impact on test Mus body weight of the table 3 different tested material
Note: compare with model group, P < 0.01, P < 0.05
From table 3, compared with obese model group, embodiment 1 significantly alleviates in i.e. achieving for the 4th week of rat oral gavage
The effect of body weight.Comparative example 1 had more significantly weight loss effect at the 6th week.Comparative example 2 achieved the most obvious at the 4th week
Weight loss effect, its effect is better than comparative example 1.Comparative example 3 had more significantly weight loss effect at the 4th week, had at the 6th week and significantly subtracts
Weight effect, its weight loss effect is better than comparative example 1 and 2.As can be seen here, the weight loss effect of embodiment 1 is best, is secondly comparative example 3,
Being comparative example 2 again, comparative example 1, the weight loss effect of comparative example 4 is worst.
2, different tested materials are shown in Table 4 to the impact of test Mus fat coefficient.
The impact on test Mus fat coefficient of the table 4 different tested material
| Group | n | Fat coefficient g/100g |
| Obese model group | 10 | 4.8±1.1 |
| Embodiment 1 | 10 | 2.2 ± 0.8 |
| Comparative example 1 | 10 | 3.2 ± 0.7 |
| Comparative example 2 | 10 | 2.7 ± 0.6 |
| Comparative example 3 | 10 | 2.6 ± 0.9 |
| Comparative example 4 | 10 | 3.8 ± 0.5 |
Note: compare with model group, P < 0.01, P < 0.05
From table 4, different tested materials process the fat coefficient to test Mus and all have a significant impact.Compared with model group,
Embodiment 1 significantly reduces the fat coefficient of test Mus, and comparative example 2 and comparative example 3 also significantly reduce fat coefficient, but effect
It is slightly worse than embodiment 1.Comparative example 1 the most significantly decreases fat coefficient, but compared with other process groups, its effect is poor.
Comparative example 4 fat reducing low effort.
Conclusion: from table 3 and table 4, loss of weight and the fat reducing effect of embodiment 1 are best.Secondly it is comparative example 3, with
Embodiment 1 is compared, and comparative example 3 is without L-carnitine-L-tartrate.Visible, still can reach without L-carnitine-L-tartrate
To preferable loss of weight and fat reducing effect.
Comparative example 2 groups has also reached more significantly loss of weight and fat reducing effect, but its effect is slightly worse than embodiment 1 and contrast
Example 3.Compared with Example 1, comparative example 2 does not add certain kind of berries fruit powder, but the many times of consumptions adding L-carnitine-L-tartrate, it is possible to
Reach the effect of loss of weight fat reducing.But L-carnitine taste bad, through sensory evaluation, as solid beverage, it is impossible to directly eat.
Compared with other process groups, the loss of weight fat reducing effect of comparative example 1 is poor, because being not added with many certain kind of berries fruit powder in comparative example 1.
Visible many certain kind of berries fruit powder important role in the composition.
In all process groups, the effect of comparative example 4 is worst.Visible, remove L-carnitine food and drink hydrochlorate and many certain kind of berries fruit powder
After, loss of weight and the fat reducing effect of compositions substantially reduce.Comparative example 4, compared with comparative example 1, removes L-carnitine-L-tartrate
After, its loss of weight and fat reducing effect substantially reduce, it is seen then that L-carnitine-L-tartrate and Semen Phaseoli Vulgaris extract have synergism.
Additionally, from the above results, said composition has good loss of weight fat reducing effect.Many certain kind of berries fruit powder plays wherein
Important effect, after removing many certain kind of berries fruit powder, significance of (comparative example 1) its effect is decreased obviously.L-carnitine-L-tartrate is also
Playing a role, after removal, (comparative example 3) its loss of weight fat reducing effect has declined.After removing many certain kind of berries fruit powder, high times amount adds
Add L-carnitine-L-tartrate and also can reach more significantly loss of weight fat reducing effect, but because its taste is the poorest, sense organ aspect cannot
Accept.Removing after L-carnitine-L-tartrate and many certain kind of berries fruit powder (comparative example 4), the loss of weight fat reducing effect of compositions is remarkably decreased,
Therefore, Semen Phaseoli Vulgaris extract, L-carnitine-L-tartrate, many certain kind of berries fruit powder three have synergism.
In the composition, add many certain kind of berries compositions and reduce the consumption of L-carnitine-L-tartrate, improve product
Overall sense organ, improves the action effect of said composition simultaneously.
The product of other embodiments we have also been made above-mentioned correlation test, conclusion (of pressure testing) is consistent with above-mentioned conclusion, at this not
Repeat explanation.
Obviously, the above embodiment of the present invention is only for clearly demonstrating example of the present invention, and is not right
The restriction of embodiments of the present invention, for those of ordinary skill in the field, the most also may be used
To make other changes in different forms, cannot all of embodiment be given exhaustive here, every belong to this
What bright technical scheme was extended out obviously changes or changes the row still in protection scope of the present invention.
Claims (10)
1. Semen Phaseoli Vulgaris many certain kind of berries compositions, it is characterised in that it includes: Semen Phaseoli Vulgaris extract 2-20 part, L-carnitine winestone
Hydrochlorate 0.1-6 part, water soluble dietary fiber 30-70 part, many certain kind of berries fruit powder 5-30 part, sugar alcohol 5-40 part, correctives 0-0.5 part.
Semen Phaseoli Vulgaris many certain kind of berries compositions the most according to claim 1, it is characterised in that described many certain kind of berries fruit powder be Fructus Fragariae Ananssae fruit powder,
At least two in Fructus Rubi fruit powder, blueberry powder, Brazilian Acai fruit powder and cranberry fruit powder.
Semen Phaseoli Vulgaris many certain kind of berries compositions the most according to claim 1 and 2, it is characterised in that described water soluble dietary fiber is
One or more in resistant dextrin, oligofructose, oligomeric galactose, oligomeric xylose, polydextrose and Rhizoma amorphophalli fiber.
Semen Phaseoli Vulgaris many certain kind of berries compositions the most according to claim 1 and 2, it is characterised in that described sugar alcohol is maltose alcohol, wood
One or more in sugar alcohol, Sorbitol, mannitol, erythritol and lactose.
Semen Phaseoli Vulgaris many certain kind of berries compositions the most according to claim 1 and 2, it is characterised in that described correctives is that Fructus Momordicae is sweet
Glycosides, one or more in stevioside, sucralose, aspartame and acesulfame potassium.
Semen Phaseoli Vulgaris many certain kind of berries compositions the most according to claim 1 and 2, it is characterised in that described compositions also includes 1-10
The fruit fruit powder of part, it is preferable that described fruit fruit powder is the one or several in apple power, Fructus Musae fruit powder and Fructus actinidiae chinensis fruit powder
Kind.
7. the preparation method of the arbitrary described Semen Phaseoli Vulgaris many certain kind of berries compositions of claim 1-5, it is characterised in that include walking as follows
Rapid: take described Semen Phaseoli Vulgaris extract, water soluble dietary fiber, sugar alcohol sieve respectively, mixing obtains mixture 1；Take described many certain kind of berries fruit
Powder, L-carnitine-L-tartrate, correctives sieve respectively, mixing, obtain mixture 2；Mixture 1 and mixture 2 are mixed, pack
Obtain.
8. the preparation method described in claim 7, it is characterised in that when preparing mixture 2, also includes the fruit adding 1-10 part
Fruit powder, it is preferable that described fruit fruit powder is one or more in apple power, Fructus Musae fruit powder and Fructus actinidiae chinensis fruit powder.
9. Semen Phaseoli Vulgaris many certain kind of berries compositions, it is characterised in that it includes: Semen Phaseoli Vulgaris extract 2-20 part, L-carnitine winestone
Hydrochlorate 0.1-6 part, resistant dextrin 20-45 part, polydextrose 10-25 part, xylitol 20-30 part, Fructus Fragariae Ananssae fruit powder 1-10 part, Fructus Rubi
Fruit powder 2-10 part, blueberry powder 2-10 part and stevioside 0-0.5 part.
10. Semen Phaseoli Vulgaris many certain kind of berries solid beverage, it is characterised in that it includes that the arbitrary described Semen Phaseoli Vulgaris of claim 1-6 is many
Semen Phaseoli Vulgaris many certain kind of berries compositions described in certain kind of berries compositions or claim 9.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610515953.0A CN106136247A (en) | 2016-07-01 | 2016-07-01 | A kind of Semen Phaseoli Vulgaris many certain kind of berries compositions and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610515953.0A CN106136247A (en) | 2016-07-01 | 2016-07-01 | A kind of Semen Phaseoli Vulgaris many certain kind of berries compositions and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106136247A true CN106136247A (en) | 2016-11-23 |
Family
ID=58061074
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610515953.0A Pending CN106136247A (en) | 2016-07-01 | 2016-07-01 | A kind of Semen Phaseoli Vulgaris many certain kind of berries compositions and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106136247A (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106690013A (en) * | 2016-12-09 | 2017-05-24 | 南陵县葛业协会 | White kidney bean flavored boiled dumpling |
| CN106819741A (en) * | 2017-01-20 | 2017-06-13 | 世茂（苏州）生物科技有限公司 | Compound fruit-flavored beverage of a kind of Isin glue collagen and preparation method thereof |
| CN107373484A (en) * | 2017-07-12 | 2017-11-24 | 新时代健康产业（集团）有限公司 | A kind of cranberry composition with antiinflammation and preparation method and application |
| CN109770361A (en) * | 2019-03-25 | 2019-05-21 | 杭州赛能医药科技有限公司 | A kind of navy bean diet fiber composition and its application |
| CN110800904A (en) * | 2018-08-06 | 2020-02-18 | 丰宁平安高科实业有限公司 | Solid beverage composition capable of effectively controlling weight and reducing fat and preparation method thereof |
| CN111657414A (en) * | 2020-06-09 | 2020-09-15 | 浙江瑾昊文化传媒有限公司 | Strawberry-flavor composite powder solid beverage and preparation method thereof |
| CN111685332A (en) * | 2020-05-19 | 2020-09-22 | 北京美信高科科技有限责任公司 | Composition with fat-reducing, body-shaping and body-beautifying functions and preparation method thereof |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1994382A (en) * | 2005-12-31 | 2007-07-11 | 王凯 | Diet composition combined by blueberry, levo-carnitine, spirulina and lotus leaf |
| CN101002619A (en) * | 2007-01-11 | 2007-07-25 | 沈阳贵虹小浆果生物技术研发中心 | Beverage containing Hongshumei fruit juice |
| CN103230021A (en) * | 2012-08-10 | 2013-08-07 | 广州市赛健生物科技有限公司 | Weight-loss health-care food and preparation method thereof |
| CN103829254A (en) * | 2013-12-20 | 2014-06-04 | 浙江大学 | Application of proanthocyanidins in preparing diet food or drug |
-
2016
- 2016-07-01 CN CN201610515953.0A patent/CN106136247A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1994382A (en) * | 2005-12-31 | 2007-07-11 | 王凯 | Diet composition combined by blueberry, levo-carnitine, spirulina and lotus leaf |
| CN101002619A (en) * | 2007-01-11 | 2007-07-25 | 沈阳贵虹小浆果生物技术研发中心 | Beverage containing Hongshumei fruit juice |
| CN103230021A (en) * | 2012-08-10 | 2013-08-07 | 广州市赛健生物科技有限公司 | Weight-loss health-care food and preparation method thereof |
| CN103829254A (en) * | 2013-12-20 | 2014-06-04 | 浙江大学 | Application of proanthocyanidins in preparing diet food or drug |
Non-Patent Citations (1)
| Title |
|---|
| 王昌涛等: "《蓝莓综合加工与应用》", 31 March 2013, 中国农业科学技术出版社 * |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106690013A (en) * | 2016-12-09 | 2017-05-24 | 南陵县葛业协会 | White kidney bean flavored boiled dumpling |
| CN106819741A (en) * | 2017-01-20 | 2017-06-13 | 世茂（苏州）生物科技有限公司 | Compound fruit-flavored beverage of a kind of Isin glue collagen and preparation method thereof |
| CN107373484A (en) * | 2017-07-12 | 2017-11-24 | 新时代健康产业（集团）有限公司 | A kind of cranberry composition with antiinflammation and preparation method and application |
| CN107373484B (en) * | 2017-07-12 | 2021-06-15 | 国珍健康科技（北京）有限公司 | Cranberry composition with anti-inflammatory effect and preparation method and application thereof |
| CN110800904A (en) * | 2018-08-06 | 2020-02-18 | 丰宁平安高科实业有限公司 | Solid beverage composition capable of effectively controlling weight and reducing fat and preparation method thereof |
| CN109770361A (en) * | 2019-03-25 | 2019-05-21 | 杭州赛能医药科技有限公司 | A kind of navy bean diet fiber composition and its application |
| CN111685332A (en) * | 2020-05-19 | 2020-09-22 | 北京美信高科科技有限责任公司 | Composition with fat-reducing, body-shaping and body-beautifying functions and preparation method thereof |
| CN111657414A (en) * | 2020-06-09 | 2020-09-15 | 浙江瑾昊文化传媒有限公司 | Strawberry-flavor composite powder solid beverage and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20210352948A1 (en) | Composition for treating diabetes based on traditional Chinese medicine nutritional therapy and application thereof | |
| CN106136247A (en) | A kind of Semen Phaseoli Vulgaris many certain kind of berries compositions and preparation method thereof | |
| CN103099089B (en) | Health-care product for reducing blood sugar and blood pressure, relaxing bowels, losing weight, resisting fatigue and improving sexual function and production technology thereof | |
| CN102919836B (en) | Health-care product capable of reducing blood glucose, releasing pressure, reducing lipid, relaxing bowel, beautifying, losing weight and resisting fatigue and production process thereof | |
| CN105077236B (en) | Compound special meals nutrient powder of the highland barley of auxiliary hyperglycemic and preparation method thereof | |
| CN104544432B (en) | Samara oil compound protein solid beverage and method for preparing same | |
| CN109645320A (en) | A kind of light jejunitas full nutrient formulation can brew instant stick and preparation method thereof | |
| US20210220422A1 (en) | Dietary supplement compositions and methods | |
| CN107319525A (en) | One kind fat-reducing fat reducing tailored version clinical nutrition formula and preparation method thereof | |
| CN102138671A (en) | Formula and preparation method of ginseng health-care cake containing eight delicacies | |
| CN101878790A (en) | Nutrification flour for diabetics and preparation method thereof | |
| CN110663872A (en) | Full-nutrient meal replacement weight-losing food, preparation method and eating method | |
| CN110447902B (en) | Composition with weight-losing effect | |
| CN101253903B (en) | Health food with fat-reducing function and its preparation | |
| CN101579120A (en) | Nutritional food with weight-losing function and preparation method thereof | |
| CN106174479A (en) | A kind of geriatric nutrition powder and preparation method thereof | |
| CN108391785A (en) | A kind of functionality meal replacement powder and its manufacture craft and application | |
| CN108477609A (en) | A kind of burdock weight losing meal-replacing stick and preparation method thereof | |
| CN110547470A (en) | A nutritional composition for improving male sexual function, and its preparation method | |
| CN107996975A (en) | A kind of quinoa weight losing meal-replacing powder containing burdock polysaccharide | |
| CN109602019A (en) | A kind of probiotic food and preparation method thereof with reduction body fat content function | |
| CN103766896A (en) | Chinese yam composite nutrient rice | |
| CN102613461B (en) | Rapidly beautifying and weight losing nourishment and preparation method thereof | |
| CN109123648A (en) | For mitigating the composition and preparation method thereof of carcinosis radiotherapy and chemotherapy toxic side effect | |
| CN105056005B (en) | A kind of integration of drinking and medicinal herbs composition of energy lower blood-fat and reduce weight |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20161123 |